Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 11, 2025Neurodegenerative Disease Management

Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer’s disease – an exploratory post hoc analysis

View Full Paper
Ask AI
Bookmark
Share

Authors

HWHui Jue WangMRMyuri RuthirakuhanAAAna C. Andreazza

Discussion

Loading...

Member takes

Overview

Exploratory analysis identifies biomarkers to predict treatment response in agitation for Alzheimer’s disease, suggesting potential personalized approaches.

Key Points

  • The aim is to identify biomarkers that can predict treatment response to nabilone in patients with Alzheimer's disease.
  • Exploratory post hoc analysis of biomarker data
  • Examined responders and non-responders to nabilone treatment
  • Focused on agitation-related outcomes
  • Identified specific biomarkers correlated with treatment response
  • Differentiated between responders and non-responders
  • Suggests potential for personalized treatment approaches based on biomarker profiles

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/69252ea8c0ce034ddc356a52https://doi.org/10.1080/17582024.2025.2587549
View Full Paper
Ask AI
Bookmark
Share